Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review

被引:1
|
作者
Kraj, Leszek [1 ,2 ]
Chmiel, Paulina [3 ]
Gryziak, Maciej [1 ]
Grabowska-Derlatka, Laretta [4 ]
Szymanski, Lukasz [2 ]
Wysokinska, Ewa [5 ]
机构
[1] Med Univ Warsaw, Univ Clin Ctr, Dept Oncol, PL-02091 Warsaw, Poland
[2] Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Mol Biol, PL-01447 Magdalenka, Poland
[3] Med Univ Warsaw, Univ Clin Ctr, PL-02091 Warsaw, Poland
[4] Med Univ Warsaw, Univ Clin Ctr, Dept Clin Radiol 2, PL-02091 Warsaw, Poland
[5] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
关键词
hepatocellular carcinoma; HCC; thrombocytopenia; platelets; outcome; tumor features; ENDOTHELIAL GROWTH-FACTOR; FACTOR-RECEPTOR-ALPHA; PLATELET COUNT; RADIOFREQUENCY ABLATION; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; HEPATITIS-B; CANCER; RESECTION; SIZE;
D O I
10.3390/cancers16071293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Currently, hepatocellular carcinoma (HCC) is one of the most prevalent oncological diagnoses worldwide. Despite intensive research into its pathogenesis and clinical course, numerous issues remain unresolved. In the presented meta-analysis and systematic review, we investigate the potential of blood platelet levels in patients with HCC for prognostic assessment. Blood platelets may play a significant role as an easily measurable laboratory parameter in assessing the prognosis of patients with HCC. Background: Platelets (PLT) have a role in the pathogenesis, progression, and prognosis of hepatocellular carcinoma (HCC) and could represent a readily measurable laboratory parameter to enhance the comprehensive evaluation of HCC patients. Methods: The PubMed, Web of Science, and Scopus databases were searched with a focus on survival as well as patient and tumor-specific characteristics in correlation to reported PLT counts. Survival outcomes were analyzed with both common-effect and random-effects models. The hazard ratio (HR) and its 95% confidence interval (CI) from analyzed trials were incorporated. Studies that did not provide survival data but focused on platelet count correlation with HCC characteristics were reviewed. Results: In total, 26 studies, including a total of 9403 patients, met our criteria. The results showed that thrombocytopenia in HCC patients was associated with poor overall survival (common-effect HR = 1.15, 95% CI: 1.06-1.25; random-effect HR = 1.30, 95% CI: 1.05-1.63). Moreover, three studies reveal significant correlations between PLT indices and tumor characteristics such as size, foci number, and etiology of HCC development. Conclusion: Our meta-analysis confirmed that PLT count could act as a prognostic marker in HCC, especially with a PLT count cut off <100 x 10(3)/mm(3). Further prospective studies focusing on the role of PLT in clearly defined subgroups are necessary.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis
    Pang, Qing
    Qu, Kai
    Bi, Jian-Bin
    Liu, Su-Shun
    Zhang, Jing-Yao
    Song, Si-Dong
    Lin, Ting
    Xu, Xin-Sen
    Wan, Yong
    Tai, Ming-Hui
    Liu, Hao-Chen
    Dong, Ya-Feng
    Liu, Chang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (25) : 7895 - 7906
  • [2] Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis
    Qing Pang
    Kai Qu
    Jian-Bin Bi
    Su-Shun Liu
    Jing-Yao Zhang
    Si-Dong Song
    Ting Lin
    Xin-Sen Xu
    Yong Wan
    Ming-Hui Tai
    Hao-Chen Liu
    Ya-Feng Dong
    Chang Liu
    World Journal of Gastroenterology, 2015, 21 (25) : 7895 - 7906
  • [3] Thrombocytopenia and the outcomes of hepatectomy for hepatocellular carcinoma: a meta-analysis
    Zhang, Zhaohui
    Zhang, Yi
    Wang, Wei
    Hua, Yunpeng
    Liu, Linyun
    Shen, Shunli
    Peng, Baogang
    JOURNAL OF SURGICAL RESEARCH, 2017, 210 : 99 - 107
  • [4] The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma A Systematic Review and Meta-Analysis
    Pang, Qing
    Qu, Kai
    Zhang, Jing-Yao
    Song, Si-Dong
    Liu, Su-Shun
    Tai, Ming-Hui
    Liu, Hao-Chen
    Liu, Chang
    MEDICINE, 2015, 94 (37)
  • [5] Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Kamiliou, Aikaterini
    Lekakis, Vasileios
    Xynos, George
    Cholongitas, Evangelos
    CANCERS, 2024, 16 (05)
  • [6] Prognostic value of osteopontin in patients with hepatocellular carcinoma A systematic review and meta-analysis
    Sun, Tingting
    Li, Peng
    Sun, Diwen
    Bu, Qingao
    Li, Guoqiang
    MEDICINE, 2018, 97 (43)
  • [7] Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma A systematic review and meta-analysis
    Xuan, Dongchun
    Wen, Weibo
    Xu, Dongyuan
    Jin, Toufeng
    MEDICINE, 2021, 100 (07) : E24585
  • [8] The impact of waiting time and delayed treatment on the outcomes of patients with hepatocellular carcinoma: A systematic review and meta-analysis
    Cheo, Feng Yi
    Lim, Celeste Hong Fei
    Chan, Kai Siang
    Shelat, Vishal Girishchandra
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2024, 28 (01) : 1 - 13
  • [9] Sorafenib combined with radiofrequency ablation as treatment for patients with hepatocellular carcinoma: a systematic review and meta-analysis
    Chen, Lin
    Ma, Xingming
    Liu, Xin
    Cui, Xiaomeng
    JOURNAL OF BUON, 2017, 22 (06): : 1525 - 1532
  • [10] Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes
    Shanker, Mihir D.
    Moodaley, Pereshin
    Soon, Wei
    Liu, Howard Y.
    Lee, Yoo Young
    Pryor, David I.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2021, 65 (07) : 956 - 968